Industry Partnerships

For over 20 years, iBET has established a strong collaboration track record with leading pharmaceutical and biotech companies globally.

Bridging the gap academia-industry

At iBET, we bridge the gap between academia and industry through collaborative R&D programs.

We are committed to maximizing knowledge creation and transfer, delivering value to our partners, the market and society.

Our focus within Biopharma R&D lies in Bioprocess development for Biopharmaceuticals, ATMPs (gene and cell-based therapies) and Vaccines.

We tackle complex challenges along the bioprocess development pipeline

Early stage R&D

Support of early-stage R&D, from cell line development and virus design and engineering to small-scale expression and purification platforms for ATMPs and vaccines, using mammalian and insect cells.

Bioprocess Development

Bioprocess expertise including Upstream Processing (devising strategies to monitor, control and optimize product titer, and quality), and Downstream Processing (developing solutions to reduce manufacturing costs while increasing product recovery yields, quality, and safety).

BioAnalytics

Development of analytical assays to characterize cells, host-virus interactions and product quality and potency. The data collected often supports the creation and informs comprehensive models that provide valuable insights into process performance.

Scale-Up

Establishment of scalable processes, compliant with GMP guidelines, to produce ATMPs, vaccines and recombinant proteins. Our capabilities include process scale-up in stirred-tank bioreactors up to 50 L.

Tech Transfer

Ensuring technology transfer to CDMOs, including shadowing of key process operations.

Early stage R&D

Support of early-stage R&D, from cell line development and virus design and engineering to small-scale expression and purification platforms for ATMPs and vaccines, using mammalian and insect cells.

Bioprocess Development

Bioprocess expertise including Upstream Processing (devising strategies to monitor, control and optimize product titer, and quality), and Downstream Processing (developing solutions to reduce manufacturing costs while increasing product recovery yields, quality, and safety).

BioAnalytics

Development of analytical assays to characterize cells, host-virus interactions and product quality and potency. The data collected often supports the creation and informs comprehensive models that provide valuable insights into process performance.

Scale-Up

Establishment of scalable processes, compliant with GMP guidelines, to produce ATMPs, vaccines and recombinant proteins. Our capabilities include process scale-up in stirred-tank bioreactors up to 50 L.

Tech Transfer

Ensuring technology transfer to CDMOs, including shadowing of key process operations.

Biopharma

How we work with Industry Partners

Satellite labs

Launched in 2009, our Satellite Labs program is a unique innovation model born from long-standing successful partnerships with international pharma companies.

Satellite laboratories benefit from fully dedicated laboratory spaces and teams exclusively devoted to research within the network of each company.
Staffed with highly skilled scientists, each satellite lab is overseen by a lab head who serves as the primary liaison, facilitating the direct communication between both entities. This ensures a deep understanding of both parties’ goals and fosters seamless collaboration with the utmost trust and confidentiality.

Satellite Lab teams benefit from access to iBET’s solid expertise on bioprocess development and complementary scientific support infrastructures, such as the Late-Stage R&D and Bioproduction Unit and the Analytical Services Unit.

Learn more about our Satellite Labs

Contract Research Projects

iBET operates with contract research projects, where project-based teams with specialized expertise design and execute each project in a bespoke manner, aligned with the specific needs of each partner. Our bespoke approach ensures maximal flexibility while still taking advantage of the iBET’s wide range of expertise and resources.

Our ongoing collaboration with iBET has been an incredibly fruitful and fulfilling partnership that has enabled the investigation, execution and development of new and exciting methodologies and ways of working. Leveraging iBET's skills and expertise and working together as a team has allowed us to accomplish more than we could have ever alone.

Michael Hoffman

Associate Director - Sanofi

Having had the pleasure of working with iBET over the past five years, I can say without hesitation that their professionalism is second to none. Across every team and individual I've collaborated with, their reliability, integrity, and clear communication have consistently set a high standard. Their research capabilities are truly exceptional—consistently thorough, rigorous, and beyond reproach. Even more impressively, their unwavering enthusiasm for tackling complex scientific challenges has made each collaboration not only productive but deeply rewarding. iBET stands out as a partner that brings both excellence and passion to every project.

Francois du Plessis

Associate Director - Boehringer Ingelheim

Collaborating with iBET over the past five years has been truly transformative. Their unwavering professionalism, genuine commitment, and heartfelt dedication have set them apart from any other CRO or CDMO I’ve encountered. iBET didn’t just join our projects, they became an extension of our team, treating each challenge as their own. Their flexibility and proactive spirit brought innovative solutions and constant support. iBET exemplifies both excellence and kindness. I am grateful for the successful years of partnership and collaboration with iBET.

Eleuterio Lombardo

Director Cell Therapy Characterization and Development - Takeda

We have been collaborating with iBET for several years for the clinical development of one of our vaccine candidate. Our work together has allowed to move the vaccine candidate from our academic laboratory into GMP MVSS and engineering run in a few years. Thanks to these products, we got excellent results in our toxicological study and the vaccine is now entering a phase 1 clinical trial. The collaboration with iBET was fruitful, rigourous, smooth and kind. The issues encountered during the development have all been solved in a timely manner and iBET team always showed strong motivation and dedication to our project. I will of course continue this collaboration for future product developments.

Sylvain Baize

Head of Biology of Viral Emerging Infections Lab - Institut Pasteur

I have had the pleasure to be a close collaborator of iBET for more than 10 years and it has been an exceptional and deeply enriching experience. Their team is extremely competent, trustworthy, and reliable, always willing to embark in new projects with dedication and collaborative spirit. Together we have been able to secure large European projects that has contributed to strength our scientific reach and our friendship. But even more importantly, their supportive and humble attitude, always willing to put a little more time and work makes them the greatest scientific partners and friends building a truly meaningful long-term collaboration.

Felipe Prósper

Co-director of Hemato-Oncology Program, Principal Investigator of the Translational Hematology Group and Head of Cellular Therapy Unit - Cima Universidad de Navarra

iBET is one of our strategic partners for research. They always do what must be done to commit with our needs and respecting the timelines. Anytime open discussions or brainstorming is required we did it successfully. It's easy to develop and run projects with iBET.

Manuel João Oliveira

General Manager - IBERFAR, Indústria Farmacêutica SA

Sustainability for Food & Health

How we can support our Industry Partners

iBET’s Sustainability for Food & Health Area can support and guide R&D projects from conception to clinical application. Through our comprehensive R&D pipeline, we leverage our expertise in natural bioactives to translate their potential into solutions that enhance consumer well-being and promote economic circularity.

Here is how we can support various industries:

Agri-food Industry

Provide support in the development of functional foods through the evaluation of their health benefits, valorization of food industry wastes by-products  by developing high-value ingredients based on natural bioatives (promoting sustainability), and ensure high sensorial and safety quality standards of food products.

Cosmetic Industry

Enhancement of formulations with natural and bioactive ingredients and explore new bioactives with beneficial effects on skin health.

Nutraceutical Industry

Explore new bioactives with potential therapeutic applications; and improve the development of new nutraceuticals by utilizing green technologies of extraction, purification and microencapsulation.

Our collaboration with iBET is built on mutual expertise and innovation, combining scientific excellence with practical industrial applications. Their multidisciplinary approach and technical support elevate our projects, driving quality, food safety, and process optimization. With iBET’s reliable partnership, we merge knowledge and teamwork to overcome challenges, transform ambitious ideas into results, and strengthen Sovena’s R&D activities.

Luis Aparicio

Corporate Quality & Food Safety Director - Sovena Group

iBET has demonstrated a standard of excellence, combining scientific rigor with a remarkable ability to collaborate with industry. The partnership established with Ascenza highlights the decisive contribution of biotechnology and applied research in overcoming complex challenges, driven by highly motivated teams in the pursuit of innovative and sustainable solutions. This approach is guided by a clear focus on value creation, transforming knowledge into tangible impact, strengthening competitiveness, and promoting responsible development within the sector.

Josué Clemente

Innovation Manager - ASCENZA Portugal

Our Industry Partners
Affilogic
Bayer
Boehringer Ingelheim
CSL Behring
Cytiva
Merck
Novartis
ReciBio Pharma
Repligen
Sanofi
Sartorius
Sumitomo Pharma
Takara
Takeda